Health · 2026-10-29 · Morning briefing

US eases rules on six peptides, bypassing FDA process

The US Department of Health and Human Services on Wednesday loosened restrictions on six unproven peptides. The new policy allows licensed pharmacists to create compounded combinations of these substances for patients with a valid prescription, provided the peptides are sourced from registered manufacturers.

The move has the support of HHS chief Robert F. Kennedy, Jr., who has previously endorsed peptides such as the "Wolverine stack"—a mix of BPC-157 and TB-500 meant to promote healing. The American Medical Association, however, sharply criticized the decision. Its president, Willie Underwood III, warned that the substances have "not undergone the rigorous testing required of FDA-approved drugs," putting patients at risk of "serious, preventable harm."

Summary written by Cup of News with AI from the sources below. Check the originals for the full story.

Read the sources

• Richard Norton’s peptide-linked death raises safety concerns as RFK Jr. eases US restrictions, bypassing US FDA
• RFK Jr. eases access to unproven peptides despite opposition from FDA scientists
• FDA scientists opposed the Trump administration’s effort to ease peptides access
• What are peptides? FDA may ease restrictions on unproven health fad
• The future of peptides in the US is about to become clearer. Here’s what you should know

More stories in this edition

1. Ukraine targets Moscow with over 600 drones, grounding flights
2. North Korea launches 10 ballistic missiles into sea
3. Samsung shares fall despite 783% profit jump
4. Apple's first touchscreen MacBook Pro costs up to $14,549
5. Study: 75% of deceased NFL players likely had brain disease
6. Brazilian senator Flávio Bolsonaro lands in US amid probes
7. Poland and India target $10bn trade as Warsaw pivots from China
8. Justice demanded in Tanzania a year after 518 election deaths
9. UK delays soldier's extradition in 2012 Kenya murder case until 2027

Read the whole edition